Healthcare Costs of Switching from Cigarettes to Smokeless Tobacco in COPD Patients
Author Information
Author(s): Zhang Mingda, Cheng Hui G., Noggle Brendan, Janak Jud C., Richards Megan, Smith David
Primary Institution: Altria Client Services LLC
Hypothesis
What is the impact of transitioning from cigarette smoking to smokeless tobacco on healthcare costs among adult male patients with COPD?
Conclusion
The study found that quitting tobacco or switching to smokeless tobacco may lead to reductions in direct healthcare costs for patients with COPD.
Supporting Evidence
- Patients who quit tobacco had the highest average healthcare costs at baseline.
- Switching to smokeless tobacco showed a trend towards reduced healthcare costs.
- Healthcare costs decreased for all cohorts in the follow-up period.
Takeaway
If you stop smoking or switch to a different type of tobacco, you might spend less on healthcare.
Methodology
A retrospective cohort study using healthcare claims data to compare healthcare costs before and after smoking behavior changes.
Potential Biases
Potential misclassification of smoking status and reliance on administrative claims data may introduce bias.
Limitations
The study is limited to individuals with commercial or Medicare coverage, and the small size of the smokeless tobacco cohort may affect the results.
Participant Demographics
Adult male patients with COPD, with varying ages and comorbidities.
Statistical Information
P-Value
0.08
Confidence Interval
95% CI: -$11,067, $442
Statistical Significance
p=0.08
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website